SCHEMBL19913302

SCHEMBL19913302

Cc1cc(-c2cc(-n3c4ccccc4c4ccc(-c5ccccc5)cc43)c(C#N)c(-n3c4ccccc4c4ccc(-c5ccccc5)cc43)c2)cc(C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
HPGD P15428 4/20 0.40
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.36
HIF1A Q16665 1/20 0.36
KDM5B Q9UGL1 2/20 0.36
KDM4A O75164 1/20 0.36
PDE9A O76083 1/20 0.35
PDE1C Q14123 1/20 0.35
ADORA1 P30542 3/20 0.35
ADORA2A P29274 2/20 0.34
SQOR Q9Y6N5 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PPARG P37231 1/20 0.34
NCOA2 Q15596 1/20 0.34
NCOA1 Q15788 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19908985 0.96 ALDH1A1 (0.42) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2
SCHEMBL19913313 0.94 PDE9A (0.39) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2
SCHEMBL19909203 0.93 CHEK1 (0.38) KDM4EHPGDALDH1A1HSD17B10METAP2
SCHEMBL19908918 0.93 KDM4E (0.40) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2
SCHEMBL19909436 0.92 KDM5B (0.40) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2
SCHEMBL19909216 0.92 ALDH1A1 (0.38) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2
SCHEMBL19913312 0.92 KDM5B (0.39) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2
SCHEMBL19909179 0.92 SQOR (0.37) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2
SCHEMBL19919668 0.91 ADORA2A (0.38) ALDH1A1HSD17B10ADORA1ADORA2ACYP1A2
SCHEMBL23487617 0.91 KDM4E (0.38) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 KDM4E 4526/4885HPGD 2205/4885ALDH1A1 297/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 KDM4E 4526/4885HPGD 2205/4885ALDH1A1 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.